A Division of Cornerstone Family Healthcare
HVCS’ Frank Barone, a member of our Syringe Exchange Program staff, will be on the panel at the upcoming 2018 Sullivan County Opioid Abuse Prevention Conference at the Bethel Woods Center for the Arts on Wednesday, October 3, 2018. Frank is one of the featured local speakers and his segment is entitled, “I Was Twelve: My Story of the Road to Recovery.”
Get all the details and register for the conference here.
Free Community Narcan Training
Sponsored by Ulster County Sheriff Paul VanBlarcum
Awareness Inc. Marie Shultis and Young People in Recovery
Hudson Valley Community Services Inc.
Free Narcan Kits will be given. Please come with questions.
Narcan (naloxone) is an opioid antagonist and is used for the complete or partial reversal of opioid overdose, including respiratory depression. It is also used for diagnosis of suspected or known acute opioid overdose and also for blood pressure support in septic shock.
R.S.V.P. to Awareness Inc. at 845-417-1484 or by email at: ucawarenessprogram@gmail.com
Saturday, June 23rd, 2018
8:00AM-1:00PM
The NYSDOH AIDS Institute is sponsoring a free buprenorphine waiver training for clinical providers. In response to opioid overdose deaths in New York State, increased access to buprenorphine treatment for opioid use disorder is urgently needed.
Physicians, Nurse Practitioners, Physician Assistants and Medical Residents are welcome and highly encouraged to attend. Under current regulations, authorized practitioners (MDs, DOs, NPs & PAs) are required to obtain a ‘waiver’ to prescribe buprenorphine. To acquire this waiver, physicians are required to complete a standardized buprenorphine waiver 8-hour training. Nurse Practitioners (NPs) and Physician Assistants (PAs) are required to complete the standardized buprenorphine waiver 8-hour training as well as an additional 16 hours of online training as established by the Comprehensive Addiction and Recovery Act (CARA). Residents may also take the course and apply for their waiver once they receive their DEA license. The buprenorphine waiver 8-hour training is offered in a half-and-half format [4.5 hours of in-person training followed up by 3.5 hours of online training]. Upon completion of the required training, providers will meet the requirement of the DATA 2000 to apply for a waiver to prescribe buprenorphine for opioid-dependent patients. Please contact us for further information.
CME CREDITS: The School of Public Health, University at Albany is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians. The School of Public Health, University at Albany designates this live activity for a maximum of 5.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Trainers: Kelly Ramsey, MD, Hudson River Healthcare, Poughkeepsie, NY; Samara Gabree, NP, Catholic Charities, Albany, NY
Location: Dutchess County Department of Behavioral and Community Health, 230 North Road, TRAINING ROOM Poughkeepsie, NY 12601 Light refreshments will be provided.
Directions: https://goo.gl/maps/YkTgJx7ByJm
Online Registration: https://goo.gl/UqhKwF
Questions: NYSDOH, AIDS Institute, Office of Drug User Health Stephen Crowe, 212-417-4558, stephen.crowe@health.ny.gov Belinda Duncan, 1-800-692-8528, buprenorphine@health.ny.gov
ACCREDITATION: This activity has been planned and implemented by NYSDOH, AIDS Institute in accordance with the accreditation requirements and policies of the American Academy of Addiction Psychiatry (AAAP) and in partnership with Dutchess County Health Department and Montefiore Hudson Valley. Funding for this course was made possible (in part) by 1U79TI026556 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. American Academy of Addiction Psychiatry is the sponsoring data organization.
Buprenorphine Waiver Eligibility
Training for Clinical Providers: Ulster County
Saturday, May 12th, 2018
8:00AM-1:00PM
The NYSDOH AIDS Institute is sponsoring a free buprenorphine waiver training for clinical providers. In response to opioid overdose deaths in New York State, increased access to buprenorphine treatment for opioid use disorder is urgently needed. Physicians, Nurse Practitioners, Physician Assistants and Medical Residents are welcome and highly encouraged to attend.
Under current regulations, authorized practitioners (MDs, DOs, NPs & PAs) are required to obtain a ‘waiver’ to prescribe buprenorphine. To acquire this waiver, physicians are required to complete a standardized buprenorphine waiver 8-hour training. Nurse Practitioners (NPs) and Physician Assistants (PAs) are required to complete the standardized buprenorphine waiver 8-hour training as well as an additional 16 hours of online training as established by the Comprehensive Addiction and Recovery Act (CARA). Residents may also take the course and apply for their waiver once they receive their DEA license. The buprenorphine waiver 8-hour training is offered in a half-and-half format [4.5 hours of in-person training followed up by 3.5 hours of online training]. Upon completion of the required training, providers will meet the requirement of the DATA 2000 to apply for a waiver to prescribe buprenorphine for opioid-dependent patients. Please contact us for further information.
CME CREDITS: The School of Public Health, University at Albany is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians. The School of Public Health, University at Albany designates this live activity for a maximum of 5.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Trainer: Melissa Weimer DO, MCR, St. Peter’s Health Partners, Albany, NY
Location: Health Alliance Hospital, 105 Marys Avenue Campus, William De Doux Administrative Conference Room, Kingston, NY 12401 Light refreshments will be provided.
Directions: https://goo.gl/maps/RPzN5GamScq
Online Registration: https://goo.gl/UACSpW
Questions: NYSDOH, AIDS Institute, Office of Drug User Health
Stephen Crowe, 212-417-4558, stephen.crowe@health.ny.gov
Belinda Duncan, 212-417-4553, buprenorphine@health.ny.gov
ACCREDITATION: This activity has been planned and implemented by NYSDOH, AIDS Institute in accordance with the accreditation requirements and policies of the American Academy of Addiction Psychiatry (AAAP) and in partnership with Westchester Medical Center Health Care Network.
Funding for this course was made possible (in part) by 1U79TI026556 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. American Academy of Addiction Psychiatry is the sponsoring data organization.
Saturday, June 30th, 2018
8:00AM-1:00PM
The NYSDOH AIDS Institute is sponsoring a free buprenorphine waiver training for clinical providers. In response to opioid overdose deaths in New York State, increased access to buprenorphine treatment for opioid use disorder is urgently needed. Physicians, Nurse Practitioners, Physician Assistants and Medical Residents are welcome and highly encouraged to attend.
Under current regulations, authorized practitioners (MDs, DOs, NPs & PAs) are required to obtain a ‘waiver’ to prescribe buprenorphine. To acquire this waiver, physicians are required to complete a standardized buprenorphine waiver 8-hour training. Nurse Practitioners (NPs) and Physician Assistants (PAs) are required to complete the standardized buprenorphine waiver 8-hour training as well as an additional 16 hours of online training as established by the Comprehensive Addiction and Recovery Act (CARA). Residents may also take the course and apply for their waiver once they receive their DEA license. The buprenorphine waiver 8-hour training is offered in a half-and-half format [4.5 hours of in-person training followed up by 3.5 hours of online training]. Upon completion of the required training, providers will meet the requirement of the DATA 2000 to apply for a waiver to prescribe buprenorphine for opioid-dependent patients. Please contact us for further information.
CME CREDITS: The School of Public Health, University at Albany is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians. The School of Public Health, University at Albany designates this live activity for a maximum of 5.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Trainer: Melissa Weimer DO, MCR, St. Peter’s Health Partners, Albany, NY
Location: Good Samaritan Hospital, 255 Lafayette Avenue, Auditorium, Suffern, NY 10901 Light refreshments will be provided.
Directions: https://goo.gl/maps/KP557fUfeFJ2
Online Registration: https://goo.gl/kU6mVw
Questions: NYSDOH, AIDS Institute, Office of Drug User Health
Stephen Crowe, 212-417-4558, stephen.crowe@health.ny.gov
Belinda Duncan, 212-417-4553, buprenorphine@health.ny.gov
ACCREDITATION: This activity has been planned and implemented by NYSDOH, AIDS Institute in accordance with the accreditation requirements and policies of the American Academy of Addiction Psychiatry (AAAP) and in partnership with Westchester Medical Center, Health Care Network.
Funding for this course was made possible (in part) by 1U79TI026556 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government. American Academy of Addiction Psychiatry is the sponsoring data organization.
Narcan Training and Community AWARENESS with Parents, High School Students and Adolescents sharing their experiences, hope and their peer to peer program that helps them help others.
Narcan (naloxone) is an opioid antagonist and is used for the complete or partial reversal of opioid overdose, including respiratory depression. It is also used for diagnosis of suspected or known acute opioid overdose and also for blood pressure support in septic shock. Free Narcan Kits will be given after the training.
Sponsored by New Paltz High School, Awareness Inc. and Hudson Valley Community Services.
RSVP Required To Reserve A Space: ucawarenessprogram@gmail.c
Snow Date: February 8, 2018
New York State is in crisis. Opioid overdose now takes the lives of more New Yorkers than homicides, traffic accidents and suicides combined. New York State Assemblyman Frank Skartados invites Hudson Valley residents to become a part of the solution and to join together to discuss a compassionate community response to opioid overdose deaths in New York’s 104th District. On Saturday, January 20th from 2-5 p.m. New York State Assemblyman Frank K. Skartados will be holding a town hall and forum panel on opioid overdose at the Newburgh Armory Unity Center 321 S William St, Newburgh, NY 12550.
AM Skartados has partnered with Hudson Valley Community Services (HVCS) and other agencies, including Adelphi University, Cornerstone Family Health, Drug Policy Alliance, Hudson Valley Community Services, Team Newburgh United Way of the Dutchess-Orange Region, and VOCAL-NY, to join people impacted by opioid use with experts in the fields of science, public health, criminal justice, and drug policy. HVCS’ Frank Barone, a member of our Syringe Exchange Program staff, will take part in a panel discussion.
This event will begin a compassionate and scientifically-informed discussion about drug use, overdose and New Yorkers’ best prospects for saving lives and living well. Information about local services available to people who use drugs and people in recovery will also be provided. Overdose and addiction affect us in a variety of ways.
The following experts and residents will field questions during the forum:
Keynote: Carl Hart, PhD Columbia University and Drug Policy Alliance
Kassandra Frederique, MSW Drug Policy Alliance
Judith Branche, MD, CornerStone Family Health
Jeff Kaufmann, Law Enforcement Action Partnership (LEAP)
Frank Barone, Hudson Valley Community Services
Lauren Mandel, RN Newburgh resident and nurse
Sgt. Julio Fernandez, Adelphi University School of Social Work
Those interested may register online at: https://vocal.ourpowerbase.net/civicrm/event/register?cid=0&reset=1&id=1598
or share and follow the Facebook Event: https://www.facebook.com/events/1854211644870945/
Calendar Information:
What: Town Hall on Opioid Overdose
Where: Newburgh Armory Unity Center, Larkin Center, 321 S. William St., Newburgh NY 12550
When: Saturday, January 20, 2018, 2:00 pm to 5:00 pm
Who: Concerned residents of New York’s 104th District and those affected by and concerned about opioid overdoses
More information: Contact Jawanza Williams, jawanza@vocal-ny.org
For individuals with prescription coverage through their health insurance plans, this program will cover the cost of co-payments for naloxone up to $40 so there are no or lower out-of-pocket expenses when accessing naloxone at participating pharmacies. All Medicaid Managed Care Plans cover at least one formulation of naloxone, and the vast majority of private insurance plans also cover naloxone.
There are 2,000 pharmacies throughout the State who dispense naloxone with a physician standing order. Individuals getting naloxone at these pharmacies do not need a prescription. There is no individual enrollment requirement to use N-CAP. Maximizing pharmacy distribution increases access to naloxone.
For a directory of pharmacies with standing orders, please access the link below:
https://www.health.ny.gov/diseases/aids/general/opioid_overdose_prevention/directories.htm
This directory is updated monthly.
Individuals who cannot access naloxone from pharmacies will continue to access naloxone through registered programs including individuals using naloxone in the line of duty and people who are uninsured.
Additional information regarding N-CAP can be found at: www.health.ny.gov/overdose.
The NYSDOH AIDS Institute and Sullivan County Public Health Services are hosting a Free Buprenorphine Eligibility Waiver Training for Clinical Providers (Physicians, Nurse Practitioners, Physician Assistants, Pharmacists, and Medical Residents) on Saturday, December 2nd, 2017 from 8:00AM to 1:00PM at Catskills Regional Medical Center, 68 Harris-Bushville Rd, Board Room, Harris, NY 12742.
As you may know, Sullivan County has some of the highest rates of opioid overdose in New York State. In just the first seven months of 2017, Sullivan County has experienced a reported 20 overdose deaths. From 2013-2016, there were approximately 75 reported opioid overdose deaths. We know these numbers are higher, and continue to increase due to access to fentanyl. We are seeking to increase the volume of providers in and around your county that are able to offer medication assisted treatment (MAT) to people using opioids whom could benefit from buprenorphine (or “suboxone”).
Attached is a flyer with further information, including location, online registration, and more details. Further information will be sent out to confirmed attendees. Light refreshments will be provided. Registration closes on November 29th at 5pm.
Trainers:
Sharon Stancliff, MD, Harm Reduction Coalition, New York, NY
Bruce Trigg, MD, Harm Reduction Coalition, New York, NY
Please Note: CME Credits will be made available. This is the first half of the minimum required 8 hours of training, and the second half must be completed online after attendance to the live training. Currently NPs & PAs are required to take an additional 16 hours of online training which is available on the PCSS-MAT website (Part 2).
For more information about buprenorphine related trainings, mentoring, coaching, technical assistance and more, please contact us at buprenorphine@health.ny.gov or 1-800-692-8528.
From a press release issued by Gov. Cuomo on Monday, August 7, 2017
GOVERNOR CUOMO ANNOUNCES NO-COST OR LOWER-COST NALOXONE AVAILABLE AT PHARMACIES ACROSS NEW YORK
First-in-the-Nation Program Offers Co-Payment Assistance For Medicine to Reverse Opioid Overdoses Beginning August 9, 2017
Expands State’s Aggressive Efforts to Fight the Opioid Epidemic
Governor Andrew M. Cuomo today announced a first-in-the-nation program to provide no-cost or lower-cost naloxone at pharmacies across New York. Beginning August 9, 2017, individuals with prescription health insurance coverage, including Medicaid and Medicare, will receive up to $40 in co-payment assistance, resulting in reduced cost or no cost for this lifesaving medicine. Uninsured individuals and individuals without prescription coverage will still be able to receive naloxone at no cost through New York’s network of registered opioid overdose prevention programs.
“This first-in-the-nation program will help put this lifesaving treatment in more hands and is one more prong in this administration’s efforts to battle heroin and opioid abuse,” Governor Cuomo said. “This is one more step toward a stronger, healthier New York for all.”
Naloxone is a medicine used to reverse opioid overdoses. Reducing the cost of this lifesaving medication builds on Governor Cuomo’s previous action to make naloxone available in pharmacies without a prescription which began in January 2016. Previously, New Yorkers could only receive naloxone with a prescription or through a registered opioid overdose prevention program.
As of August 9, 2017, New Yorkers can find co-payment information at pharmacy counters across the state and at: www.health.ny.gov/overdose. Individuals should provide this information to the pharmacist when asking for naloxone in order to receive it with no or lower out-of-pocket expense. The Naloxone Co-payment Assistance Program is funded by New York State’s Opioid Overdose Prevention Program.
Additionally, through New York’s network of registered opioid overdose prevention programs, uninsured individuals and individuals without prescription coverage will be able to receive naloxone at no cost. A full list of these programs is available here.
In the 2017 State Budget, Governor Cuomo invested over $200 million to fight the heroin and opioid epidemic. This unprecedented support is directed at prevention, treatment and recovery programs that address chemical dependency, expand residential service opportunities and promote public awareness and education.
Naloxone Saves Lives
Naloxone is a prescription medication used to reverse the effects of overdoses caused by heroin, prescription pain medication and other opioids. In 2014, state agencies began working together to develop a statewide program to train law enforcement personnel on how to administer naloxone. Since the trainings began, over 10,000 officers have been trained to administer the drug and 3,091 officers have been certified to train other officers.
Trained law enforcement officers across New York are saving lives with the naloxone they carry. Since April of 2014, 2,036 officers have administered naloxone to over 3,100 individuals, saving the lives of nearly 90 percent of the individuals that required assistance.
View a fact sheet on law enforcement naloxone training and usage, here.
New York State Department of Health Commissioner Dr. Howard Zucker said, “Naloxone is very effective at reversing opioid overdoses. Under Governor Cuomo’s leadership, New York State has taken comprehensive actions to stem the tide of opioid abuse, from increasing the number of treatment beds to making important health insurance reforms to eliminate barriers to accessing substance use services. The new copayment assistance program will make naloxone more available in communities across New York and save lives.”
New York State Office of Alcoholism and Substance Abuse Services Commissioner Arlene González-Sánchez said, “By guaranteeing affordable Naloxone to all New Yorkers, we will save thousands of lives and help repair the damage done to our communities by the opioid epidemic. Saving lives is the ultimate goal of all of our prevention, treatment, and recovery initiatives, and with this latest effort, Governor Cuomo is once again establishing New York State as a national leader in the field of addiction care.”
Chair of the Senate Committee on Alcoholism and Drug Abuse George Amedore said, “By increasing access to this effective remedy for drug overdoses, we are taking yet another step forward in combatting the heroin and opioid epidemic. I commend the Governor for removing barriers to help establish a stronger, healthier New York for generations.”
Chair of the Assembly Committee on Alcoholism and Drug Abuse Linda B. Rosenthal said, “New York’s communities are hard-struck by the heroin and opioid epidemic, and we must turn the tide by preventing more overdose deaths. Governor Cuomo’s plan to expand access to lifesaving naloxone through a new low-cost or no-cost co-payment system will help those struggling with this disease. By increasing access to Naloxone and cutting costs related to this lifesaving medication, New Yorkers in every corner of the state will be better equipped to save lives and help people receive the treatment they need. I look forward to working closely with the Administration to continue expanding access to overdose prevention and greater treatment options.”
Chair of the Senate Health Committee Kemp Hannon said, “The health and well-being of residents is our top priority. I look forward to working with the Governor to bring this treatment to our most vulnerable men and women, so that communities will be empowered to save the lives of thousands.”
Harm Reduction Coalition Medical Director Dr. Sharon Stancliff said, “This program will dramatically increase access to naloxone for people we haven’t easily reached. These include patients being treated for pain, loved ones of people returning from drug treatment or incarceration and people at risk in rural areas. This is a crisis and New York’s copayment assistance program adds to the solution.”
###